Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | THRB | P10828 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.52 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL558064 | 0.98 | ALDH1A1 (0.70) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL29878426 | 0.84 | CYP3A4 (0.65) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL245052 | 0.82 | ALDH1A1 (0.96) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL30040301 | 0.81 | NR4A1 (0.61) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL436522 | 0.81 | NR4A1 (0.61) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| Hydrochloric Acid SCHEMBL3020904 | 0.80 | ALDH1A1 (1.00) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| Mequinol SCHEMBL6750117 | 0.79 | ALDH1A1 (0.81) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL27657589 | 0.79 | MEN1 (0.45) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| Hydrochloric Acid SCHEMBL10770715 | 0.79 | NR4A1 (0.58) | ALDH1A1MEN1MAPTTHRBKMT2A | |
| SCHEMBL19809245 | 0.79 | NR4A1 (0.58) | ALDH1A1MEN1MAPTTHRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103491937-B | Oxidative dyeing composition comprising 1-hexyl/heptyl-4, 5-diaminopyrazole and 2-aminophenol and derivatives thereof | 宝洁公司 | 2016-08-31 | — | — | CN | claimed |
| CN-103491937-A | Oxidative dyeing composition comprising 1-hexyl/heptyl-4, 5-diaminopyrazole and 2-aminophenol and derivatives thereof | PROCTER & GAMBLE | 2014-01-01 | — | — | CN | claimed |
| US-20030069149-A1 | Inhibitor for inhibiting carbonaceous powder from heating up/spontaneously igniting and method of inhibiting carbonaceous powder from heating up/spontaneously igniting | LION CORPORATION (JP) | 2003-04-10 | — | — | US | claimed |
| EP-0070016-A1 | Method and composition for increasing reproduction in mammalian and avian species | THE UNIVERSITY OF UTAH (US) | 1983-01-19 | — | — | EP | claimed |
| EP-4741389-A1 | KAT6 INHIBITOR | Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | CHECKMATE THERAPEUTICS INC. (KR) | 2026-01-22 | — | — | US | disclosed |
| US-12497460-B2 | Anti-MSR1 antibodies and methods of use thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2025-12-16 | — | — | US | disclosed |
| WO-2025245046-A1 | COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF | ANIMA BIOTECH INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| CN-119948034-A | Novel peptide-based nitrile compound and application thereof | 上海壹迪生物技术有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-113226470-B | Rifamycin analogs and antibody-drug conjugates thereof | 瑞泽恩制药公司 | 2025-05-06 | — | — | CN | disclosed |
| EP-4543863-A1 | FERROPTOSIS INHIBITORS AND USES THEREOF | University Of Ottawa (CA) | 2025-04-30 | — | — | EP | disclosed |
| WO-2025036382-A1 | SULFONAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海复宏汉霖生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| EP-0030436-B1 | 2-HYDROXYOXANILIC ACID DERIVATIVES AND SALTS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1984-05-09 | — | — | EP | disclosed |
| US-4429133-A | OPTICAL BRIGHTENERS FOR POLYACRYLONITRILE | SANDOZ LTD. (CH) | 1984-01-31 | — | — | US | disclosed |
| EP-0070016-A1 | Method and composition for increasing reproduction in mammalian and avian species | THE UNIVERSITY OF UTAH (US) | 1983-01-19 | — | — | EP | disclosed |
| EP-0030436-A1 | 2-Hydroxyoxanilic acid derivatives and salts, their preparation and pharmaceutical compositions containing them | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1981-06-17 | — | — | EP | disclosed |
| US-4157444-A | ANTIPSYCHOTIC, NEUROLEPTIC | AMERICAN CYANAMID COMPANY (US) | 1979-06-05 | — | — | US | disclosed |
| US-4144235-A | ANTIPSYCHOTIC, NEUROLEPTIC | AMERICAN CYANAMID COMPANY (US) | 1979-03-13 | — | — | US | disclosed |
| US-4003875-A | ULTRAVIOLET ABSORBERS | CIBA-GEIGY CORPORATION (US) | 1977-01-18 | — | — | US | disclosed |
| US-3996210-A | OPTICAL BRIGHTENERS | SANDOZ LTD. (CH) | 1976-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069149-A1 | Inhibitor for inhibiting carbonaceous powder from heating up/spontaneously igniting and method of inhibiting carbonaceous powder from heating up/spontaneously igniting | CBS, UPP1, NOS1 | ALDH1A1 4031/4885MEN1 982/4885MAPT 436/4885 |
| US-12497460-B2 | Anti-MSR1 antibodies and methods of use thereof | CD47, MSR1, LDLR | ALDH1A1 3728/4885MEN1 1417/4885MAPT 4571/4885 |
| US-20260022122-A1 | NOVEL COMPOUND FOR INHIBITING NAMPT, AND COMPOSITION INCLUDING SAME | NAMPT, NAPRT, NNT | ALDH1A1 789/4885MEN1 2486/4885MAPT 1402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.